Kite Pharma Investor
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.
Technology:
Atrificial Vectors and Immune Cells, CAR-T, CAR-T therapy, Cell_Therapies
Industry:
Atrificial Vectors and Immune Cells, CAR-T, Delisted
Headquarters:
Los Angeles, California, United States
Founded Date:
2009-01-01
Employees Number:
101-250
Funding Status:
M&A
Investor Type:
Venture Capital
Number Of Exits:
3
Acquisitions Number:
Made Acquisitions, Was Acquired
Investors Number:
4
Total Funding:
285125000
Estimated Revenue:
$10B+
Last Funding Date:
2015-12-10
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership